Belgian pharmaceuticals group UCB plans to cut its headcount by 2,000 -- 17 percent of its worldwide staff -- as part of a restructuring, the company said Thursday.
It will make around 2,400 positions redundant and create about 400 new positions, and at the same time will re-deploy an estimated 300 positions to UCB's core sites.
More
No comments:
Post a Comment